ArrayPatch Ltd, a biotechnology firm based in Cork, Ireland, has completed the first close of a €3 million seed funding round. The company is focused on advancing ITZ-Dermap™, a microneedle-based therapeutic designed to treat nail fungus. This funding will support further development and clinical progress of the product.
The investment marks a significant step for ArrayPatch as it aims to bring innovative treatment options to patients suffering from onychomycosis, a common fungal infection affecting nails.
**Why this matters**
Nail fungus is a widespread condition that can be difficult to treat effectively with existing therapies. ArrayPatch’s microneedle technology offers a potentially more efficient and targeted delivery method, which could improve treatment outcomes. The successful funding round highlights investor confidence in the company’s approach and the potential impact of ITZ-Dermap™ on patient care.
Source: NewsData